In DS cellular models, EGCG enhances mitochondrial oxidative phosphorylation by activating the cAMP/PKA and Sirtuin 1 (Sirt1)/PGC-1α signaling pathways, rescuing CI and ATP synthase activities while reducing excessive ROS production [138]. Here, PPARGC1A is linked to Dravet syndrome.